Citations (149)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Alfonso Quintás-Cardama, Matjaz Sever, Jorge Cortes, Hagop Kantarjian & Srdan Verstovsek. (2013) Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis. Leukemia & Lymphoma 54:9, pages 1959-1964.
Read now
Read now
Leonie K Ashman & Renate Griffith. (2013) Therapeutic targeting of c-KIT in cancer. Expert Opinion on Investigational Drugs 22:1, pages 103-115.
Read now
Read now
Wolfgang R Sperr & Peter Valent. (2012) Diagnosis, progression patterns and prognostication in mastocytosis. Expert Review of Hematology 5:3, pages 261-274.
Read now
Read now
Michel Arock & Peter Valent. (2010) Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert Review of Hematology 3:4, pages 497-516.
Read now
Read now
Aaron Polliack, Koen van Besien & John F. Seymour. (2008) 2007: The year in review for Leukemia and Lymphoma. Leukemia & Lymphoma 49:1, pages 1-3.
Read now
Read now
Stefan Florian, Karoline Sonneck, Alexander W. Hauswirth, Maria-Theresa Krauth, Gerit-Holger Schernthaner, Wolfgang R. Sperr & Peter Valent. (2006) Detection of molecular targets on the surface of CD34+/CD38− stem cells in various myeloid malignancies. Leukemia & Lymphoma 47:2, pages 207-222.
Read now
Read now
Articles from other publishers (143)
Clayton A. MacDonald, Hui Qian, Priyanka Pundir & Marianna Kulka. (2023) Sodium butyrate supresses malignant human mast cell proliferation, downregulates expression of KIT and promotes differentiation. Frontiers in Allergy 4.
Crossref
Crossref
Tiziana Annese, Roberto Tamma, Mariella Bozza, Alfredo Zito & Domenico Ribatti. (2022) Autocrine/Paracrine Loop Between SCF+/c-Kit+ Mast Cells Promotes Cutaneous Melanoma Progression. Frontiers in Immunology 13.
Crossref
Crossref
Alice Moncada & Alessandro Pancrazzi. 2022. Cellular and Molecular Aspects of Myeloproliferative Neoplasms – Part B. Cellular and Molecular Aspects of Myeloproliferative Neoplasms – Part B
187
220
.
Paola Di Mauro, Roberta Anzivino, Marisa Distefano & Davide Domenico Borzì. (2021) Systemic mastocytosis: The roles of histamine and its receptors in the central nervous system disorders. Journal of the Neurological Sciences 427, pages 117541.
Crossref
Crossref
Alexander Aceino, Unity Jeffery, Julie Piccione & Carolyn L. Hodo. (2020) Systemic mastocytosis with subcutaneous hemorrhage and edema in a Greyhound dog: case report and review of diagnostic criteria. Journal of Veterinary Diagnostic Investigation 33:1, pages 95-100.
Crossref
Crossref
Jon van der Walt, Attilio Orazi & Daniel A. ArberTracy George & Amy Jencks. 2020. Diagnostic Bone Marrow Haematopathology. Diagnostic Bone Marrow Haematopathology
181
199
.
G. J. Molderings, F. L. Dumoulin, J. Homann, B. Sido, J. Textor, M. Mücke, G. J. Qagish, R. Barion, M. Raithel, D. Klingmüller, V. S. Schäfer, H. J. Hertfelder, D. Berdel, G. Tridente, L. B. Weinstock & L. B. Afrin. (2020) Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness. Naunyn-Schmiedeberg's Archives of Pharmacology 393:9, pages 1573-1580.
Crossref
Crossref
Bogusław Nedoszytko, Marta Sobalska-Kwapis, Dominik Strapagiel, Magdalena Lange, Aleksandra Górska, Joanne N. G. Oude Elberink, Jasper van Doormaal, Marcin Słomka, Leszek Kalinowski, Marta Gruchała-Niedoszytko, Roman J. Nowicki, Peter Valent & Marek Niedoszytko. (2020) Results from a Genome-Wide Association Study (GWAS) in Mastocytosis Reveal New Gene Polymorphisms Associated with WHO Subgroups. International Journal of Molecular Sciences 21:15, pages 5506.
Crossref
Crossref
Anne Sophie Kubasch, Georg-Nikolaus Franke, Ali Aldaoud, Konstantin Weibl, Madlen Jentzsch, Osama Sabri, Hans-Peter Horny, Falko Fend, Gerhard Behre, Uwe Platzbecker & Vladan Vucinic. (2020) Allogeneic Hematopoietic Stem Cell Transplantation in a Rare Case of Tonsillar Mast Cell Sarcoma. Frontiers in Oncology 10.
Crossref
Crossref
Hyejoo Park, Dongchan Kim, Youngil Koh & Sung-Soo Yoon. (2019) The upregulation of Pim kinases is essential in coordinating the survival, proliferation, and migration of KIT D816V-mutated neoplastic mast cells. Leukemia Research 83, pages 106166.
Crossref
Crossref
Domenico RibattiDomenico Ribatti. 2019. The Mast Cell. The Mast Cell
5
14
.
Michael P. Whyte. 2018. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
853
860
.
Lorenzo Falchi & Srdan Verstovsek. (2018) Kit Mutations. Immunology and Allergy Clinics of North America 38:3, pages 411-428.
Crossref
Crossref
Saikat Sengupta, Sujoy Khan, Chandrashish Chakravarty, Manidipam Chatterjee, Shilpa Bhartia & Vikash Agarwal. (2018) Indolent systemic mastocytosis manifesting as protracted anaphylactic shock. Indian Journal of Critical Care Medicine 22:4, pages 311-313.
Crossref
Crossref
Lakshmi Reddy Palam, Raghuveer Singh Mali, Baskar Ramdas, Sridhar Nonavinkere Srivatsan, Valeria Visconte, Ramon V. Tiu, Bart Vanhaesebroeck, Axel Roers, Alexander Gerbaulet, Mingjiang Xu, Sarath Chandra Janga, Clifford M. Takemoto, Sophie Paczesny & Reuben Kapur. (2018) Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway. JCI Insight 3:4.
Crossref
Crossref
Jader Freire Sobral Filho. (2018) Cutaneous Mastocytoma in Childhood: Case Report. Journal of Dermatology & Cosmetology 2:1.
Crossref
Crossref
Iolanda Conde-Fernandes, Rita Sampaio, Filipa Moreno, José Palla-Garcia, Maria dos Anjos Teixeira, Inês Freitas, Esmeralda Neves, Maria Jara-Acevedo, Luis Escribano & Margarida Lima. (2017) Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcome. Allergy, Asthma & Clinical Immunology 13:1.
Crossref
Crossref
D. Smiljkovic, K. Blatt, G. Stefanzl, Y. Dorofeeva, C. Skrabs, M. Focke‐Tejkl, W. R. Sperr, U. Jaeger, R. Valenta & P. Valent. (2017) BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils. Allergy 72:11, pages 1666-1676.
Crossref
Crossref
Wojciech Gorczyca. 2017. Flow Cytometry in Neoplastic Hematology. Flow Cytometry in Neoplastic Hematology
434
450
.
Richard M. Stone & Charles A. Schiffer. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
31
.
Joon Hyuk Suh, Kui Young Park & Seong Jun Seo. (2017) Urticaria Pigmentosa Mimicking Multiple Lentigine-like Brownish Macules in a 22-Month-Old Boy. Journal of Korean Medical Science 32:6, pages 885.
Crossref
Crossref
Arnaud Payerols, Eric Frouin, Aurélie Schiffmann, Nicolas Menjot de Champfleur, Danielle Canioni, Olivia Chandesris, Valérie Costes, Max Villain & Frédéric Mura. (2016) Exophthalmos, Diplopia, and Bilateral Eyelid Edema: Symptoms of Ocular Mastocytosis. Optometry and Vision Science 93:11, pages 1440-1443.
Crossref
Crossref
Ayesha Abid, Michael A. Malone & Katherine Curci. (2016) Mastocytosis. Primary Care: Clinics in Office Practice 43:3, pages 505-518.
Crossref
Crossref
Harvinder Virk, Greer Arthur & Peter Bradding. (2016) Mast cells and their activation in lung disease. Translational Research 174, pages 60-76.
Crossref
Crossref
J. J. Thompson, J. A. Morrison, D. L. Pearl, S. E. Boston, G. A. Wood, R. A. Foster & B. L. Coomber. (2015) Receptor Tyrosine Kinase Expression Profiles in Canine Cutaneous and Subcutaneous Mast Cell Tumors. Veterinary Pathology 53:3, pages 545-558.
Crossref
Crossref
Deepti Radia. 2016. Managing Myeloproliferative Neoplasms. Managing Myeloproliferative Neoplasms
97
107
.
T. Gülen, H. Hägglund, B. Dahlén & G. Nilsson. (2016) Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. Journal of Internal Medicine 279:3, pages 211-228.
Crossref
Crossref
Sassine Ghanem, Gwenalyn Garcia, Liu Ying, Matthew Hurford & Marcel Odaimi. (2016) Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case. Case Reports in Oncological Medicine 2016, pages 1-6.
Crossref
Crossref
Kjell Öberg. 2016. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
1833
1853
.
R. Divekar & J. Butterfield. (2015) Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders. Allergy 70:10, pages 1230-1238.
Crossref
Crossref
Julie K. Kim & David A. Khan. (2015) Idiopathic Anaphylaxis—A Diagnostic and Therapeutic Dilemma. Current Treatment Options in Allergy 2:3, pages 183-192.
Crossref
Crossref
Anindya Chatterjee, Joydeep Ghosh & Reuben Kapur. (2015) Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder. Oncotarget 6:21, pages 18250-18264.
Crossref
Crossref
M Arock, K Sotlar, C Akin, S Broesby-Olsen, G Hoermann, L Escribano, T K Kristensen, H C Kluin-Nelemans, O Hermine, P Dubreuil, W R Sperr, K Hartmann, J Gotlib, N C P Cross, T Haferlach, A Garcia-Montero, A Orfao, J Schwaab, M Triggiani, H-P Horny, D D Metcalfe, A Reiter & P Valent. (2015) KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis. Leukemia 29:6, pages 1223-1232.
Crossref
Crossref
Juan Redondo Mateo, Aránzazu García Mateo, Carmen Delgado Mucientes & Karen Romero Figueroa. (2015) Mastocitosis sistémica indolente. Piel 30:4, pages 218-221.
Crossref
Crossref
Yaxia Zhang, Andrew E. Rosenberg, Lester J. Layfield & G. Petur Nielsen. 2015. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology
1008
1124
.
Gerhard J. Molderings. (2015) The genetic basis of mast cell activation disease - looking through a glass darkly. Critical Reviews in Oncology/Hematology 93:2, pages 75-89.
Crossref
Crossref
Araceli Tobío, Amparo Alfonso & Luis M. Botana. (2015) Cross-talks between c-Kit and PKC isoforms in HMC-1560 and HMC-1560,816 cells. Different role of PKCδ in each cellular line. Cellular Immunology 293:2, pages 104-112.
Crossref
Crossref
Joelle M Fenger, Misty D Bear, Stefano Volinia, Tzu-Yin Lin, Bonnie K Harrington, Cheryl A London & William C Kisseberth. (2014) Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis. BMC Cancer 14:1.
Crossref
Crossref
S. Barete. (2014) Les mastocytoses. Annales de Dermatologie et de Vénéréologie 141:11, pages 698-714.
Crossref
Crossref
Rosine SalehGhaith Wedeh, Harald HerrmannSiham BibiSabine Cerny-ReitererIrina Sadovnik, Katharina Blatt, Emir HadzijusufovicSylvie JeanningrosCatherine BlancMagali Legarff-TavernierElise ChapiroFlorence Nguyen-KhacFrédéric SubraPatrick BonnemyePatrice DubreuilVanessa Desplat, Hélène Merle-BéralMichael WillmannThomas Rülicke, Peter ValentMichel Arock. (2014) A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection. Blood 124:1, pages 111-120.
Crossref
Crossref
Cem Akin & Peter Valent. (2014) Diagnostic Criteria and Classification of Mastocytosis in 2014. Immunology and Allergy Clinics of North America 34:2, pages 207-218.
Crossref
Crossref
Anna Kovalszki & Peter F. Weller. (2014) Eosinophilia in Mast Cell Disease. Immunology and Allergy Clinics of North America 34:2, pages 357-364.
Crossref
Crossref
Siham Bibi, Florent Langenfeld, Sylvie Jeanningros, Fabienne Brenet, Erinn Soucie, Olivier Hermine, Gandhi Damaj, Patrice Dubreuil & Michel Arock. (2014) Molecular Defects in Mastocytosis. Immunology and Allergy Clinics of North America 34:2, pages 239-262.
Crossref
Crossref
A Chaix, M-L Arcangeli, S Lopez, E Voisset, Y Yang, M Vita, S Letard, S Audebert, P Finetti, D Birnbaum, F Bertucci, M Aurrand-Lions, P Dubreuil & P De Sepulveda. (2013) KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570. Oncogene 33:7, pages 872-881.
Crossref
Crossref
Iolanda Conde Fernandes, Maria dos Anjos Teixeira, Ines Freitas, Manuela Selores, Rosario Alves & Margarida Lima. (2014) Adult mastocytosis: a review of the Santo António Hospital 's experience and an evaluation of World Health Organization criteria for the diagnosis of systemic disease. Anais Brasileiros de Dermatologia 89:1, pages 59-66.
Crossref
Crossref
Philipp Erben, Juliana Schwaab, Georgia Metzgeroth, Hans-Peter Horny, Mohamad Jawhar, Karl Sotlar, Alice Fabarius, Martina Teichmann, Sven Schneider, Thomas Ernst, Martin C. Müller, Michelle Giehl, Alexander Marx, Karin Hartmann, Andreas Hochhaus, Wolf-Karsten Hofmann, Nicholas C. P. Cross & Andreas Reiter. (2013) The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis. Annals of Hematology 93:1, pages 81-88.
Crossref
Crossref
Thomas Marichal, Mindy Tsai & Stephen J. Galli. (2013) Mast Cells: Potential Positive and Negative Roles in Tumor Biology. Cancer Immunology Research 1:5, pages 269-279.
Crossref
Crossref
Norma J. Klein & Shad Misseldine. (2013) Anesthetic considerations in pediatric mastocytosis: a review. Journal of Anesthesia 27:4, pages 588-598.
Crossref
Crossref
Marnelli A. Bautista-Quach, Cassie L. Booth, Albert Kheradpour, Craig W. Zuppan, Edward H. Rowsell, Lawrence Weiss & Jun Wang. (2013) Mast Cell Sarcoma in an Infant. Journal of Pediatric Hematology/Oncology 35:4, pages 315-320.
Crossref
Crossref
Mi Hyun Bae, Hyun-Ki Kim, Chan-Jeoung Park, Eul-Ju Seo, Sang Hyuk Park, Young-Uk Cho, Seongsoo Jang, Hyun-Sook Chi & Kyu-Hyung Lee. (2013) A Case of Systemic Mastocytosis Associated with Acute Myeloid Leukemia Terminating as Aleukemic Mast Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. Annals of Laboratory Medicine 33:2, pages 125-129.
Crossref
Crossref
Stephen J. Fuller. (2012) New Insights into the Pathogenesis, Diagnosis, and Management of Mastocytosis. Hematology/Oncology Clinics of North America 26:6, pages 1143-1168.
Crossref
Crossref
C Möller Westerberg, H Hägglund & G Nilsson. (2012) Proteasome inhibition upregulates Bim and induces caspase-3-dependent apoptosis in human mast cells expressing the Kit D816V mutation. Cell Death & Disease 3:11, pages e417-e417.
Crossref
Crossref
Dina S. El-Agamy. (2012) Targeting c-kit in the therapy of mast cell disorders: Current update. European Journal of Pharmacology 690:1-3, pages 1-3.
Crossref
Crossref
Antonio Torrelo, Iván Alvarez-Twose & Luis Escribano. (2012) Childhood mastocytosis. Current Opinion in Pediatrics 24:4, pages 480-486.
Crossref
Crossref
Isabelle Auquit-Auckbur, Câlin Lazar, Sophie Deneuve, Cécile Guillemet, Nadège Cordel, France Blanchard, Pascal Joly & Philippe Courville. (2012) Malignant Transformation of Mastocytoma Developed on Skin Mastocytosis Into Cutaneous Mast Cell Sarcoma. American Journal of Surgical Pathology 36:5, pages 779-782.
Crossref
Crossref
V. Brazzelli, V. Grasso, G. Manna, V. Barbaccia, S. Merante, E. Boveri & G. Borroni. (2012) Indolent systemic mastocytosis treated with narrow-band UVB phototherapy: study of five cases. Journal of the European Academy of Dermatology and Venereology 26:4, pages 465-469.
Crossref
Crossref
Katharina Blatt, Harald Herrmann, Irina Mirkina, Emir Hadzijusufovic, Barbara Peter, Sabine Strommer, Gregor Hoermann, Matthias Mayerhofer, Konrad Hoetzenecker, Walter Klepetko, Viviane Ghanim, Katharina Marth, Thorsten Füreder, Volker Wacheck, Rudolf Valenta & Peter Valent. (2012) The PI3-Kinase/mTOR-Targeting Drug NVP-BEZ235 Inhibits Growth and IgE-Dependent Activation of Human Mast Cells and Basophils. PLoS ONE 7:1, pages e29925.
Crossref
Crossref
Stefanie Adolf, Gunda Millonig, Helmut Karl Seitz, Andreas Reiter, Peter Schirmacher, Thomas Longerich & Sebastian Mueller. (2012) Systemic Mastocytosis: A Rare Case of Increased Liver Stiffness. Case Reports in Hepatology 2012, pages 1-6.
Crossref
Crossref
Alfonso Quintás‐Cardama, Nitin Jain & Srdan Verstovsek. (2011) Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis. Cancer 117:24, pages 5439-5449.
Crossref
Crossref
Stefanos Intzes, Susan Wiersma & Howard J. Meyerson. (2011) Myelomastocytic Leukemia With t(8;21) in a 3-year-old Child. Journal of Pediatric Hematology/Oncology 33:8, pages e372-e375.
Crossref
Crossref
Kristin Kleewein, Roland Lang, Anja Diem, Tobias Vogel, Gabriela Pohla‐Gubo, Johann W. Bauer, Helmut Hintner & Martin Laimer. (2011) Diffuse Cutaneous Mastocytosis Masquerading as Epidermolysis Bullosa. Pediatric Dermatology 28:6, pages 720-725.
Crossref
Crossref
Celalettin Ustun, David L. DeRemer & Cem Akin. (2011) Tyrosine kinase inhibitors in the treatment of systemic mastocytosis. Leukemia Research 35:9, pages 1143-1152.
Crossref
Crossref
Andrzej Mital, Anna Piskorz, Krzysztof Lewandowski, Bartosz Wasąg, Janusz Limon & Andrzej Hellmann. (2011) A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib. European Journal of Haematology 86:6, pages 531-535.
Crossref
Crossref
Youl-Nam LeeStephanie BrandalPierre NoelErik WentzelJoshua T. MendellMichael A. McDevittReuben Kapur, Melody Carter, Dean D. Metcalfe & Clifford M. Takemoto. (2011) KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation. Blood 117:13, pages 3629-3640.
Crossref
Crossref
Alexander GerbauletClaudia WickenhauserJulia ScholtenKatrin PeschkeSebastian DrubeHans-Peter HornyThomas KamradtRonald NaumannWerner Müller, Thomas KriegClaudia Waskow, Karin HartmannAxel Roers. (2011) Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit. Blood 117:6, pages 2012-2021.
Crossref
Crossref
Amandine Chaix, Sophie Lopez, Edwige Voisset, Laurent Gros, Patrice Dubreuil & Paulo De Sepulveda. (2011) Mechanisms of STAT Protein Activation by Oncogenic KIT Mutants in Neoplastic Mast Cells. Journal of Biological Chemistry 286:8, pages 5956-5966.
Crossref
Crossref
Sanjaya K. Satapathy & David Bernstein. (2011) Dermatologic Disorders and the Liver. Clinics in Liver Disease 15:1, pages 165-182.
Crossref
Crossref
Kjell Öberg. 2011. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
1809
1828
.
Maria Ekoff & Gunnar Nilsson. 2011. Mast Cell Biology. Mast Cell Biology
47
60
.
Peter Valent, Wolfgang R. Sperr & Cem Akin. (2010) How I treat patients with advanced systemic mastocytosis. Blood 116:26, pages 5812-5817.
Crossref
Crossref
BaoJin Wu, LiJing Yin, ZhengLan Lu, YuShu Yin, WeiWei Yang, Rong Yang, XiaoDong Kang, GuiJie Liu, HongPing Yin, LiPing Yu, MeiEr Gu & PeiLin Wu. (2010) Abnormal gonad development in Kit W-2Bao mice caused by a Kit gene missense mutation. Chinese Science Bulletin 55:36, pages 4143-4149.
Crossref
Crossref
Ulrich Amon, Karin Hartmann, Hans-Peter Horny & Anna Nowak. (2010) Mastocytosis - an update. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 8:9, pages 695-712.
Crossref
Crossref
Alexandra Böhm, Karoline Sonneck, Karoline V. Gleixner, Karina Schuch, Winfried F. Pickl, Katharina Blatt, Barbara Peter, Harald Herrmann, Gerit-Holger Schernthaner, Hubert Pehamberger, Werner Rabitsch, Wolfgang R. Sperr & Peter Valent. (2010) In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V. Experimental Hematology 38:9, pages 744-755.
Crossref
Crossref
Ying Yang, Sébastien Létard, Laurence Borge, Amandine Chaix, Katia Hanssens, Sophie Lopez, Marina Vita, Pascal Finetti, Daniel Birnbaum, François Bertucci, Sophie Gomez, Paulo de Sepulveda & Patrice Dubreuil. (2010) Pediatric mastocytosis–associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations. Blood 116:7, pages 1114-1123.
Crossref
Crossref
Lorenzo Deho’ & Silvia Monticelli. (2010) Human Mast Cells and Mastocytosis: Harnessing MicroRNA Expression as a New Approach to Therapy?. Archivum Immunologiae et Therapiae Experimentalis 58:4, pages 279-286.
Crossref
Crossref
Didem Ozdemir, Selcuk Dagdelen, Tomris Erbas, Kemal Agbaht, Songul Serefhanoglu, Salih Aksu & Sibel Ersoy-Evans. (2010) Hypotension, Syncope, and Fever in Systemic Mastocytosis without Skin Infiltration and Rapid Response to Corticosteroid and Cyclosporin: A Case Report. Case Reports in Medicine 2010, pages 1-4.
Crossref
Crossref
Irene Ruano, Ricardo Gargini & Marta Izquierdo. (2010) Combination of KIT gene silencing and tocopherol succinate may offer improved therapeutic approaches for human mastocytosis. British Journal of Haematology 148:1, pages 59-68.
Crossref
Crossref
Naotomo Kambe, Akane Tanaka & Yoshiki Miyachi. 2010. Therapy of Skin Diseases. Therapy of Skin Diseases
263
272
.
Emir Hadzijusufovic, Barbara Peter, Laura Rebuzzi, Christian Baumgartner, Karoline V. Gleixner, Alexander Gruze, Tuddow Thaiwong, Winfried F. Pickl, Vilma Yuzbasiyan-Gurkan, Michael Willmann & Peter Valent. (2009) Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutation. Veterinary Immunology and Immunopathology 132:2-4, pages 243-250.
Crossref
Crossref
Masayuki Yoshida, Yuji Nishikawa, Yohei Yamamoto, Yuko Doi, Takuo Tokairin, Toshiaki Yoshioka, Yasufumi Omori, Atsushi Watanabe, Naoto Takahashi, Tomoko Yoshioka, Ikuo Miura, Ken-ichi Sawada & Katsuhiko Enomoto. (2009) Mast cell leukemia with rapidly progressing portal hypertension. Pathology International 59:11, pages 817-822.
Crossref
Crossref
M.-T. Krauth, I. Mirkina, H. Herrmann, C. Baumgartner, M. Kneidinger & P. Valent. (2009) Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells. Clinical & Experimental Allergy 39:11, pages 1711-1720.
Crossref
Crossref
Franziska Ruëff, Susanne Dugas-Breit & Bernhard Przybilla. (2009) Stinging Hymenoptera and mastocytosis. Current Opinion in Allergy & Clinical Immunology 9:4, pages 338-342.
Crossref
Crossref
Luciana Cirillo Maluf, Jefferson Alfredo de Barros & Carlos D’Aparecida dos Santos Machado Filho. (2009) Mastocitose. Anais Brasileiros de Dermatologia 84:3, pages 213-225.
Crossref
Crossref
Yanli Jin, Qi Chen, Xianping Shi, Zhongzheng Lu, Chao Cheng, Yingrong Lai, Qin Zheng & Jingxuan Pan. (2009) Activity of triptolide against human mast cells harboring the kinase domain mutant KIT. Cancer Science 100:7, pages 1335-1343.
Crossref
Crossref
Darrin L. Willingham, Prith Peiris, Juan M. Canabal, Murli Krishna, Winston R. Hewitt, Timothy S. J. Shine, Lisa C. Arasi, Jaime Aranda-Michel, Christopher B. Hughes & David J. Kramer. (2009) Unexplained and prolonged perioperative hypotension after orthotopic liver transplantation: Undiagnosed systemic mastocytosis. Liver Transplantation 15:7, pages 701-708.
Crossref
Crossref
B. Nedoszytko, M. Niedoszytko, M. Lange, J. van Doormaal, J. Gleń, M. Zabłotna, J. Renke, A. Vales, F. Buljubasic, E. Jassem, J. Roszkiewicz & P. Valent. (2009)
Interleukin-13
promoter gene polymorphism -1112C/T is associated with the systemic form of mastocytosis
. Allergy 64:2, pages 287-294.
Crossref
Crossref
Anna Kay Duckworth, Asmaa Bhatti & Cheryl Barnes. (2009) Diffuse cutaneous mastocytosis in fraternal twins. International Journal of Dermatology 48:2, pages 170-172.
Crossref
Crossref
Ramon J. Mayoral, Matthew E. Pipkin, Mikhail Pachkov, Erik van Nimwegen, Anjana Rao & Silvia Monticelli. (2009) MicroRNA-221–222 Regulate the Cell Cycle in Mast Cells. The Journal of Immunology 182:1, pages 433-445.
Crossref
Crossref
Chikamasa Yoshida, Makoto Takeuchi, Junjiro Tsuchiyama & Yoshito Sadahira. (2009) Successful Treatment of KIT D816V-positive, Imatinib-resistant Systemic Mastocytosis with Interferon-alpha. Internal Medicine 48:22, pages 1973-1978.
Crossref
Crossref
Cassius I. Ochoa Chaar, Robert L. Bell, Thomas P. Duffy & Andrew J. Duffy. (2009) Guidelines for Safe Surgery in Patients with Systemic Mastocytosis. The American Surgeon 75:1, pages 74-80.
Crossref
Crossref
Malisha R Johnson, Srdan Verstovsek, Jeffrey L Jorgensen, T Manshouri, Raja Luthra, Dan M Jones, Carlos E Bueso-Ramos, L Jeffrey Medeiros & Yang O Huh. (2008) Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow. Modern Pathology 22:1, pages 50-57.
Crossref
Crossref
Tzu-Yin Lin, Rachael Thomas, Pei-Chien Tsai, Matthew Breen & Cheryl A. London. (2009) Generation and characterization of novel canine malignant mast cell line CL1. Veterinary Immunology and Immunopathology 127:1-2, pages 114-124.
Crossref
Crossref
Jennifer J. Clark, Jason N. Berman & A. Thomas Look. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood
331
402
.
Dean D. Metcalfe. 2009. Middleton's Allergy: Principles and Practice. Middleton's Allergy: Principles and Practice
1051
1062
.
Marcus Maurer. 2009. Braun-Falco’s Dermatology. Braun-Falco’s Dermatology
1511
1517
.
Rakhee Kar, Seema Rao & Hara Prasad Pati. (2009) Systemic mastocytosis with acute myelomonocytic leukemia: a case report. Indian Journal of Hematology and Blood Transfusion 24:4, pages 182-185.
Crossref
Crossref
Y. Aranda García, M. Caballero Sánchez, G. Reviriego Jaén & B. Vidiella Eguiliz. (2008) Mastocitosis sistémica como causa de síncope. SEMERGEN - Medicina de Familia 34:9, pages 459-462.
Crossref
Crossref
Laura D. BrileyCharles M. Phillips. (2008) Cutaneous Mastocytosis: A Review Focusing on the Pediatric Population. Clinical Pediatrics 47:8, pages 757-761.
Crossref
Crossref
E. J. Soilleux, C. Grills & S. M. Cooper. (2008) Cutaneous mastocytosis in human immunodeficiency virus: an unfortunate coincidence?. Clinical and Experimental Dermatology 33:5, pages 619-621.
Crossref
Crossref
R. Foster, E. Byrnes, C. Meldrum, R. Griffith, G. Ross, E. Upjohn, A. Braue, R. Scott, G. Varigos, P. Ferrao & L.K. Ashman. (2008) Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT. British Journal of Dermatology.
Crossref
Crossref
Dean D. Metcalfe. (2008) Mast cells and mastocytosis. Blood 112:4, pages 946-956.
Crossref
Crossref
. 2008. Cytogenetics, FISH and Molecular Testing in Hematologic Malignancies. Cytogenetics, FISH and Molecular Testing in Hematologic Malignancies
125
242
.
F. Wimazal, C. Baumgartner, K. Sonneck, C. Zauner, P. Geissler, S. Schur, P. Samorapoompichit, L. Müllauer, M. Födinger, H. Agis, W. R. Sperr & P. Valent. (2008) Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression. European Journal of Clinical Investigation 38:6, pages 447-455.
Crossref
Crossref
Alexander W. Hauswirth, Manuela Födinger, Marika Fritz, Leonhard Müllauer, Ingrid Simonitsch-Klupp, Berthold Streubel, Andreas Chott, Wolfgang R. Sperr, Ulrich Jäger & Peter Valent. (2008) Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease. Human Pathology 39:6, pages 917-924.
Crossref
Crossref
I. Silva, S. Carvalho, P.L. Pinto, S. Machado & J. Rosado Pinto. (2008) Mastocytosis: a rare case of anaphylaxis in paediatric age and literature review. Allergologia et Immunopathologia 36:3, pages 154-163.
Crossref
Crossref
Olivier Hermine, Olivier Lortholary, Phillip S. Leventhal, Adeline Catteau, Frédérique Soppelsa, Cedric Baude, Annick Cohen-Akenine, Fabienne Palmérini, Katia Hanssens, Ying Yang, Hagay Sobol, Sylvie Fraytag, David Ghez, Felipe Suarez, Stéphane Barete, Philippe Casassus, Beatrice Sans, Michel Arock, Jean Pierre Kinet, Patrice Dubreuil & Alain Moussy. (2008) Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis. PLoS ONE 3:5, pages e2266.
Crossref
Crossref
Beate M. Henz. (2008) Exploring the mast cell enigma: a personal reflection of what remains to be done. Experimental Dermatology 17:2, pages 91-99.
Crossref
Crossref
Jason K Lee, Scott J Whittaker, Robert A Enns & Peter Zetler. (2008) Gastrointestinal manifestations of systemic mastocytosis. World Journal of Gastroenterology 14:45, pages 7005.
Crossref
Crossref
Yasuo Hirayama, Yuich Konuma, Kyuhei Kohda, Masakatsu Ando, Masahiko Obata, Yoshinori Ueno, Yutaka Sasagawa, Yuko Wada & Sayaka Shirao. (2008) Systemic Mastocytosis without the Typical Mutation of Codon 816 Successfully Treated with Imatinib典型的c-kit codon 816の変異が認められないためイマチニブ投与を試み有効であった全身性肥満細胞増多症の1例. Nihon Naika Gakkai Zasshi 97:10, pages 2542-2545.
Crossref
Crossref
Faramarz Naeim. 2008. Hematopathology. Hematopathology
477
488
.
Ralph Waesch, Werner Digel, Michael Luebbert, Kristina Heining-Mikesch, Cornelius Waller, W. Lange, Jürgen Heinz, Jürgen Finke, Jan Burger, Gerald Illerhaus, Reinhard Marks, Alexandros Spyridonidis, Claudia I. Müller, Monika Engelhardt & Marcus Stockschläder. 2008. Concise Manual of Hematology and Oncology. Concise Manual of Hematology and Oncology
400
526
.
Sumimasa Nagai, Motoshi Ichikawa, Tsuyoshi Takahashi, Hiroyuki Sato, Hiromitsu Yokota, Kumi Oshima, Koji Izutsu, Akira Hangaishi, Yoshinobu Kanda, Toru Motokura, Shigeru Chiba, Yutaka Yatomi & Mineo Kurokawa. (2007) The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia. Experimental Hematology 35:11, pages 1747-1752.
Crossref
Crossref
Edwige Voisset, Sophie Lopez, Patrice Dubreuil & Paulo De Sepulveda. (2007) The tyrosine kinase FES is an essential effector of KITD816V proliferation signal. Blood 110:7, pages 2593-2599.
Crossref
Crossref
Russell P. Gollard, Christine Ruemmler-Fish & Diana Garcia. (2007) Systemic Mastocytosis: documented pathologic response to imatinib. European Journal of Haematology 79:4, pages 367-368.
Crossref
Crossref
Tania Zuluaga Toro, Fred H. Hsieh, Juraj Bodo, Henry Y. Dong & Eric D. Hsi. (2007) Detection of phospho-STAT5 in mast cells: a reliable phenotypic marker of systemic mast cell disease that reflects constitutive tyrosine kinase activation. British Journal of Haematology 139:1, pages 31-40.
Crossref
Crossref
Sonia S. Kupfer, John Hart & Smruti R. Mohanty. (2007) Aggressive systemic mastocytosis presenting with hepatic cholestasis. European Journal of Gastroenterology & Hepatology 19:10, pages 901-905.
Crossref
Crossref
Alberto Orfao, Andrés C. Garcia-Montero, Laura Sanchez & Luis Escribano. (2007) Recent advances in the understanding of mastocytosis: the role of KIT mutations. British Journal of Haematology 138:1, pages 12-30.
Crossref
Crossref
Frank Siebenhaar, Wolfgang Kühn, Torsten Zuberbier & Marcus Maurer. (2007) Successful treatment of cutaneous mastocytosis and Ménière disease with anti-IgE therapy. Journal of Allergy and Clinical Immunology 120:1, pages 213-215.
Crossref
Crossref
Paul A. Greenberger. (2007) Idiopathic Anaphylaxis. Immunology and Allergy Clinics of North America 27:2, pages 273-293.
Crossref
Crossref
Brian L. Swick, Larisa Ravdel, James E. Fitzpatrick & William A. Robinson. (2007) Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene ? implications for treatment with imatinib mesylate. Journal of Cutaneous Pathology 34:4, pages 324-329.
Crossref
Crossref
Julia Proelss, Joerg Wenzel, Yon Ko, Thomas Bieber & Ralf Bauer. (2007) Tryptase detection in bone-marrow blood: A new diagnostic tool in systemic mastocytosis. Journal of the American Academy of Dermatology 56:3, pages 453-457.
Crossref
Crossref
Doreen Kowatzki, Joachim W Fluhr, Peter Elsner & Mirjana Ziemer. (2007) Generalized Pruritic Reddish-Brown Patches in a 7-Year-Old Boy. American Journal of Clinical Dermatology 8:5, pages 321-323.
Crossref
Crossref
Enrico Baroni, Mauro Biffi, Fabio Benigni, Antonia Monno, Donatella Carlucci, Geert Carmeliet, Roger Bouillon & Daniele D’Ambrosio. (2007) VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3. Journal of Leukocyte Biology 81:1, pages 250-262.
Crossref
Crossref
Jingxuan PanAlfonso Quintás-CardamaHagop M. KantarjianCem AkinTaghi ManshouriPeter LambJorge E. CortesAyalew TefferiFrancis J. GilesSrdan Verstovsek. (2006) EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation. Blood 109:1, pages 315-322.
Crossref
Crossref
Franziska Ruëff & Bernhard Przybilla. 2007. Fortschritte der praktischen Dermatologie und Venerologie 2006. Fortschritte der praktischen Dermatologie und Venerologie 2006
389
395
.
Christopher L. Corless, Patina Harrell, Mario Lacouture, Troy Bainbridge, Claudia Le, Ken Gatter, Clifton WhiteJrJr, Scott Granter & Michael C. Heinrich. (2006) Allele-Specific Polymerase Chain Reaction for the Imatinib-Resistant KIT D816V and D816F Mutations in Mastocytosis and Acute Myelogenous Leukemia. The Journal of Molecular Diagnostics 8:5, pages 604-612.
Crossref
Crossref
Srdan Verstovsek, Cem Akin, Taghi Manshouri, Alfonso Quintás-Cardama, Ly Huynh, Paul Manley, Ayalew Tefferi, Jorge Cortes, Francis J. Giles & Hagop Kantarjian. (2006) Effects of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, on human mast cells bearing wild-type or mutated codon 816 c-kit. Leukemia Research 30:11, pages 1365-1370.
Crossref
Crossref
Brian P Rubin & Anette Duensing. (2006) Mechanisms of resistance to small molecule kinase inhibition in the treatment of solid tumors. Laboratory Investigation 86:10, pages 981-986.
Crossref
Crossref
Alfonso Quintas‐Cardama, Ahmed Aribi, Jorge Cortes, Francis J. Giles, Hagop Kantarjian & Srdan Verstovsek. (2006) Novel approaches in the treatment of systemic mastocytosis. Cancer 107:7, pages 1429-1439.
Crossref
Crossref
Katherine A. Lundeen, Binggang Sun, Lars Karlsson & Anne M. Fourie. (2006) Leukotriene B4 Receptors BLT1 and BLT2: Expression and Function in Human and Murine Mast Cells. The Journal of Immunology 177:5, pages 3439-3447.
Crossref
Crossref
A. Pardanani, C. Akin & P. Valent. (2006) Pathogenesis, clinical features, and treatment advances in mastocytosis. Best Practice & Research Clinical Haematology 19:3, pages 595-615.
Crossref
Crossref
Todd M. Wilson, Dean D. Metcalfe & Jamie Robyn. (2006) Treatment of Systemic Mastocytosis. Immunology and Allergy Clinics of North America 26:3, pages 549-573.
Crossref
Crossref
Joseph H. Butterfield. (2006) Systemic Mastocytosis: Clinical Manifestations and Differential Diagnosis. Immunology and Allergy Clinics of North America 26:3, pages 487-513.
Crossref
Crossref
Neil P. ShahFrancis Y. LeeRoger LuoYibin JiangMarjolein DonkerCem Akin. (2006) Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis. Blood 108:1, pages 286-291.
Crossref
Crossref
Cem Akin, Peter Valent & Luis Escribano. (2006) Urticaria pigmentosa and mastocytosis: The role of immunophenotyping in diagnosis and determining response to treatment. Current Allergy and Asthma Reports 6:4, pages 282-288.
Crossref
Crossref
K De Keersmaecker & J Cools. (2005) Chronic myeloproliferative disorders: a tyrosine kinase tale. Leukemia 20:2, pages 200-205.
Crossref
Crossref
Christoph Walz & Martin Sattler. (2006) Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML). Critical Reviews in Oncology/Hematology 57:2, pages 145-164.
Crossref
Crossref
Marcus M. Schittenhelm, Sharon Shiraga, Arin Schroeder, Amie S. Corbin, Diana Griffith, Francis Y. Lee, Carsten Bokemeyer, Michael W.N. Deininger, Brian J. Druker & Michael C. Heinrich. (2006) Dasatinib (BMS-354825), a Dual SRC/ABL Kinase Inhibitor, Inhibits the Kinase Activity of Wild-Type, Juxtamembrane, and Activation Loop Mutant KIT Isoforms Associated with Human Malignancies. Cancer Research 66:1, pages 473-481.
Crossref
Crossref
Jamie Robyn & Dean D. Metcalfe. 2006.
169
243
.
Jacques P. Zappulla, Patrice Dubreuil, Sabine Desbois, Sébastien Létard, Nadine Ben Hamouda, Marc Daëron, Georges Delsol, Michel Arock & Roland S. Liblau. (2005) Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation. The Journal of Experimental Medicine 202:12, pages 1635-1641.
Crossref
Crossref
Markku Miettinen & Jerzy Lasota. (2005) KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation. Applied Immunohistochemistry & Molecular Morphology 13:3, pages 205-220.
Crossref
Crossref
Eun Ju HuhSo Young ParkSang Rhim ChoiSeung Yeon ChungJin Han KangKyoung Mee KimJe Hoon LeeDae Chul Jeong. (2005) Aggressive Systemic Mastocytosis Following Ovarian Germ Cell Tumor. The Korean Journal of Hematology 40:2, pages 129.
Crossref
Crossref
Isabel Colmenero, Antonio Torrelo & Miguel Reyes-Múgica. 2016. Essentials of Surgical Pediatric Pathology. Essentials of Surgical Pediatric Pathology
1
42
.